Jade Biosciences, Inc.
JBIO- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- SEC CIK
- 0001798749
No open-market purchases or sales by Jade Biosciences, Inc. insiders were filed in the last 90 days; 153 institutions reported holding it in 13F filings for Q2 2026, worth $1.62B in total; no superinvestor holds it.
13F holders, Q1 2023
Institutional positions in Jade Biosciences, Inc. as of Mar 31, 2023. Investment managers with $100 million or more in US stocks report their long positions on Form 13F within 45 days after each quarter ends. How 13F works
- Institutional holders
- 66
- −4 vs. Q4 2022
- Shares held
- 26.0M
- −1.42M (−5.2%) vs. Q4 2022
- Total value
- $524.1M
- −$278.8M (−34.7%) vs. Q4 2022
- New holders
- 6
- 23 more added
- Sold out
- 10
- 25 more reduced
Compare with Q4 2022: new holders, sold out and not filed yet
Holders and value by quarter
Institutions reporting JBIO on Form 13F each quarter since Q1 2021, and the total value they reported. Values are as of each quarter end, so they also move with the share price.
| Quarter | Holders | Value |
|---|---|---|
| Q2 2026 | 153 | $1.62B |
| Q1 2026 | 120 | $700.3M |
| Q4 2025 | 105 | $726.3M |
| Q3 2025 | 78 | $272.9M |
| Q2 2025 | 75 | $315.1M |
| Q1 2025 | 82 | $79.6M |
| Q4 2024 | 80 | $79.9M |
| Q3 2024 | 75 | $57.8M |
| Q2 2024 | 81 | $45.1M |
| Q1 2024 | 81 | $841.5M |
| Q4 2023 | 64 | $637.8M |
| Q3 2023 | 58 | $386.3M |
| Q2 2023 | 60 | $488.3M |
| Q1 2023 | 66 | $524.1M |
| Q4 2022 | 70 | $802.9M |
| Q3 2022 | 56 | $447.4M |
| Q2 2022 | 51 | $403.0M |
| Q1 2022 | 46 | $475.5M |
| Q4 2021 | 47 | $301.6M |
| Q3 2021 | 41 | $452.6M |
| Q2 2021 | 18 | $454.4M |
| Q1 2021 | 0 | $0 |
Institutions, Q1 2023
Shares, value and share of portfolio for each institution holding Jade Biosciences, Inc.; share changes are against Q4 2022.
| Institution | Shares | Value | % of portfolio | Change in shares | Action |
|---|---|---|---|---|---|
| Nisa Investment Advisors, LLC | 4 | $0 | 0.00% | 00.0% | Unchanged |
| Ellevest, Inc. | 7 | $141 | 0.00% | +4+133.3% | Added |
| Federated Hermes, Inc. | 202 | $4.07K | 0.00% | +118+140.5% | Added |
| Citigroup Inc | 229 | $4.62K | 0.00% | −120−34.4% | Reduced |
| Royal Bank of Canada | 515 | $10.0K | 0.00% | −983−65.6% | Reduced |
| Metropolitan Life Insurance Co | 701 | $14.1K | 0.00% | 00.0% | Unchanged |
| Ameritas Investment Partners, Inc. | 772 | $15.6K | 0.00% | 00.0% | Unchanged |
| Russell Investments Group, Ltd. | 939 | $18.9K | 0.00% | −236−20.1% | Reduced |
| Amalgamated Bank | 987 | $20.0K | 0.00% | −212−17.7% | Reduced |
| Wells Fargo & Company | 1,636 | $33.0K | 0.00% | +1,636 | New |
| STRS Ohio | 2,300 | $46.0K | 0.00% | 00.0% | Unchanged |
| Tower Research Capital LLC (TRC) | 2,702 | $55.0K | 0.00% | +1,558+136.2% | Added |
| Legal & General Group Plc | 3,431 | $69.2K | 0.00% | +196+6.1% | Added |
| American International Group, Inc. | 4,432 | $89.4K | 0.00% | +88+2.0% | Added |
| Barclays PLC | 4,720 | $95.2K | 0.00% | +850+22.0% | Added |
| MetLife Investment Management | 5,228 | $105.4K | 0.00% | 00.0% | Unchanged |
| Deutsche Bank AG | 5,639 | $113.7K | 0.00% | +1,857+49.1% | Added |
| UBS Group AG | 5,986 | $120.7K | 0.00% | +5,986 | New |
| JPMorgan Chase & Co | 7,084 | $143.0K | 0.00% | +1,817+34.5% | Added |
| New York State Common Retirement Fund | 7,684 | $155.0K | 0.00% | +11+0.1% | Added |
| Golden State Equity Partners | 10,530 | $212.4K | 0.11% | +10,530 | New |
| California State Teachers Retirement System | 10,959 | $221.0K | 0.00% | −122−1.1% | Reduced |
| Two Sigma Investments, LP | 11,509 | $232.1K | 0.00% | −9,628−45.6% | Reduced |
| Dimensional Fund Advisors LP | 11,614 | $234.3K | 0.00% | +11,614 | New |
| Trustees of Columbia University in the City of New York | 13,190 | $266.0K | 0.48% | 00.0% | Unchanged |
| Bank of America Corp | 13,302 | $268.3K | 0.00% | +5,746+76.0% | Added |
| Rhumbline Advisers | 14,798 | $298.0K | 0.00% | +566+4.0% | Added |
| Ensign Peak Advisors, Inc | 15,000 | $302.6K | 0.00% | −6,208−29.3% | Reduced |
| HighVista Strategies LLC | 15,833 | $319.4K | 0.26% | +15,833 | New |
| D. E. Shaw & Co., Inc. | 15,958 | $321.9K | 0.00% | −13,536−45.9% | Reduced |
| Alps Advisors Inc | 16,208 | $326.9K | 0.00% | −477−2.9% | Reduced |
| Renaissance Technologies LLC | 17,600 | $355.0K | 0.00% | −500−2.8% | Reduced |
| Swiss National Bank | 18,601 | $375.2K | 0.00% | −2,100−10.1% | Reduced |
| Millennium Management LLC | 20,792 | $419.0K | 0.00% | −102,416−83.1% | Reduced |
| Charles Schwab Investment Management Inc | 24,641 | $497.0K | 0.00% | 00.0% | Unchanged |
| Parkwood LLC | 25,863 | $522.0K | 0.10% | +5,303+25.8% | Added |
| Bank of New York Mellon Corp | 27,795 | $560.6K | 0.00% | −299−1.1% | Reduced |
| Nuveen Asset Management, LLC | 36,310 | $732.0K | 0.00% | −802−2.2% | Reduced |
| Boothbay Fund Management, LLC | 39,573 | $798.2K | 0.02% | +13,760+53.3% | Added |
| Morgan Stanley | 44,974 | $907.1K | 0.00% | +42,784+1,953.6% | Added |
| Nan Fung Group Holdings Ltd | 47,936 | $966.9K | 0.66% | −2,680−5.3% | Reduced |
| Eversept Partners, LP | 50,242 | $1.01M | 0.09% | −41,010−44.9% | Reduced |
| Skandinaviska Enskilda Banken AB (publ) | 50,866 | $1.03M | 0.01% | −2,474−4.6% | Reduced |
| Point72 Asset Management, L.P. | 69,119 | $1.39M | 0.00% | −105,903−60.5% | Reduced |
| Northern Trust Corp | 77,439 | $1.56M | 0.00% | −760−1.0% | Reduced |
| Nantahala Capital Management, LLC | 95,000 | $1.92M | 0.18% | +79,300+505.1% | Added |
| Fred Alger Management, LLC | 104,048 | $2.10M | 0.01% | −43,907−29.7% | Reduced |
| State Street Corp | 184,593 | $3.72M | 0.00% | −7,591−3.9% | Reduced |
| Geode Capital Management, LLC | 187,499 | $3.78M | 0.00% | +8,903+5.0% | Added |
| Ikarian Capital, LLC | 195,146 | $3.94M | 1.63% | +67,225+52.6% | Added |
| Ghost Tree Capital, LLC | 200,000 | $4.03M | 1.53% | +65,000+48.1% | Added |
| Frazier Life Sciences Management, L.P. | 338,110 | $6.82M | 0.49% | +338,110 | New |
| Vanguard Group Inc | 513,312 | $10.4M | 0.00% | +13,835+2.8% | Added |
| FMR LLC | 570,965 | $11.5M | 0.00% | +113,778+24.9% | Added |
| BlackRock Inc. | 599,999 | $12.1M | 0.00% | −7,984−1.3% | Reduced |
| OUP Management Co., LLC | 603,762 | $12.2M | 24.30% | 00.0% | Unchanged |
| Octagon Capital Advisors LP | 621,712 | $12.5M | 1.81% | 00.0% | Unchanged |
| Great Point Partners LLC | 755,620 | $15.2M | 3.01% | +377,098+99.6% | Added |
| OrbiMed Advisors LLC | 756,930 | $15.3M | 0.30% | −2,610−0.3% | Reduced |
| VR Adviser, LLC | 833,927 | $16.8M | 3.28% | +86,058+11.5% | Added |
| TCG Crossover Management, LLC | 1,081,274 | $21.8M | 4.25% | 00.0% | Unchanged |
| Cormorant Asset Management, LP | 1,561,696 | $31.5M | 2.07% | −395,436−20.2% | Reduced |
| Baker Bros. Advisors LP | 1,963,479 | $39.6M | 0.22% | −13,389−0.7% | Reduced |
| Atlas Venture Life Science Advisors, LLC | 2,039,249 | $41.1M | 5.57% | +21,728+1.1% | Added |
| Sofinnova Investments, Inc. | 3,758,686 | $75.8M | 5.14% | 00.0% | Unchanged |
| Ra Capital Management, L.P. | 8,263,982 | $166.7M | 3.77% | 00.0% | Unchanged |
| Citadel Advisors LLC | 0 | $0 | 0.00% | −1,561,923−100.0% | Sold out |
| Soleus Capital Management, L.P. | 0 | $0 | 0.00% | −217,119−100.0% | Sold out |
| Invesco Ltd. | 0 | $0 | 0.00% | −72,579−100.0% | Sold out |
| Silverarc Capital Management, LLC | 0 | $0 | 0.00% | −36,906−100.0% | Sold out |
| Cheyne Capital Management (UK) LLP | 0 | $0 | 0.00% | −18,927−100.0% | Sold out |
| Price T Rowe Associates Inc | 0 | $0 | 0.00% | −13,225−100.0% | Sold out |
| Credit Suisse AG | 0 | $0 | 0.00% | −9,071−100.0% | Sold out |
| State of Wisconsin Investment Board | 0 | $0 | 0.00% | −8,567−100.0% | Sold out |
| Old Well Partners, LLC | 0 | $0 | 0.00% | −8,092−100.0% | Sold out |
| Cubist Systematic Strategies, LLC | 0 | $0 | 0.00% | −3,206−100.0% | Sold out |